Logo image
Back
SARS-CoV-2 infection unevenly impacts metabolism in the coronal periphery of the lungs
Journal article   Open access   Peer reviewed

SARS-CoV-2 infection unevenly impacts metabolism in the coronal periphery of the lungs

Jarrod Laro, Biyun Xue, Jian Zheng, Monica Ness, Stanley Perlman and Laura-Isobel McCall
iScience, Vol.28(2), 111727
02/2025
DOI: 10.1016/j.isci.2024.111727
PMCID: PMC11848469
PMID: 39995861
url
https://doi.org/10.1016/j.isci.2024.111727View
Published (Version of record) Open Access

Abstract

SARS-CoV-2, the virus responsible for COVID-19, is a highly contagious virus that can lead to hospitalization and death. COVID-19 is characterized by its involvement in the lungs, particularly the lower lobes. To improve patient outcomes and treatment options, a better understanding of how SARS-CoV-2 impacts the body, particularly the lower respiratory system, is required. In this study, we sought to understand the spatial impact of COVID-19 on the lungs of mice infected with mouse-adapted SARS2-N501YMA30. Overall, infection caused a decrease in fatty acids, amino acids, and most eicosanoids. When analyzed by segment, viral loads were highest in central lung tissue, while metabolic disturbance was highest in peripheral tissue. Infected peripheral lung tissue was characterized by lower levels of fatty acids and amino acids when compared to central lung tissue. This study highlights the spatial impacts of SARS-CoV-2 and helps explain why peripheral lung tissue is most damaged by COVID-19. [Display omitted] •COVID-19 significantly decreases amino acids, fatty acids, and most eicosanoids•SARS-CoV-2 preferentially localizes to central lung tissue•Metabolic disturbance is highest in peripheral tissue, not central like viral load•Spatial metabolomics allows detection of metabolites not altered overall
 Amino Acids Metabolism COVID-19 Fatty acids LC-MS Lungs Metabolomics Mouse Model SARS-CoV-2 Spatial Metabolomics

Details

Metrics

6 Record Views
Logo image